Other Species / Isoforms
  UBQLN2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S8-p
MAENGESsGPPRPSR
0 1
UBQLN2 (human) MAENGESsGPPRPSR S8-p
UBQLN2 (mouse) MAENGESsGPPRPSR S8-p
UBQLN2 (rat) MAENGESSGPPRPSR S8
S23-p
GPAAAQGsAAAPAEP
0 1
UBQLN2 (human) GPAAAQGsAAAPAEP S23-p
UBQLN2 (mouse) GPAAAPGAAsPPAEP A23
UBQLN2 (rat) GPAAAPGAANPPAEP A23
A25
AAAQGsAAAPAEPkI
0 18
UBQLN2 (human) AAAQGsAAAPAEPkI A25
UBQLN2 (mouse) AAAPGAAsPPAEPkI S25-p
UBQLN2 (rat) AAAPGAANPPAEPKI N25
K31-ub
AAAPAEPkIIkVTVK
0 2
UBQLN2 (human) AAAPAEPkIIkVTVK K31-ub
UBQLN2 (mouse) AsPPAEPkIIKVTVK K31-ub
UBQLN2 (rat) ANPPAEPKIIKVTVK K31
K34-ub
PAEPkIIkVTVKTPk
0 2
UBQLN2 (human) PAEPkIIkVTVKTPk K34-ub
UBQLN2 (mouse) PAEPkIIKVTVKTPk K34
UBQLN2 (rat) PAEPKIIKVTVKTPK K34
K41-ub
kVTVKTPkEkEEFAV
0 71
UBQLN2 (human) kVTVKTPkEkEEFAV K41-ub
UBQLN2 (mouse) KVTVKTPkEkEEFAV K41-ub
UBQLN2 (rat) KVTVKTPKEkEEFAV K41
K43
TVKTPkEKEEFAVPE
0 1
UBQLN2 (human) TVKTPkEKEEFAVPE K43
UBQLN2 (mouse) TVKTPkEKEEFAVPE K43
UBQLN2 (rat) TVKTPKEkEEFAVPE K43-ac
K43-ub
TVKTPkEkEEFAVPE
0 95
UBQLN2 (human) TVKTPkEkEEFAVPE K43-ub
UBQLN2 (mouse) TVKTPkEkEEFAVPE K43-ub
UBQLN2 (rat) TVKTPKEKEEFAVPE K43
K58-ub
NSSVQQFkEAISKRF
0 5
UBQLN2 (human) NSSVQQFkEAISKRF K58-ub
UBQLN2 (mouse) NSTVQQFkEAISKRF K58-ub
UBQLN2 (rat) NSTVQQFKEAISKRF K58
K66-ub
EAISKRFksQTDQLV
0 20
UBQLN2 (human) EAISKRFksQTDQLV K66-ub
UBQLN2 (mouse) EAISKRFkSQTDQLV K66-ub
UBQLN2 (rat) EAISKRFKSQTDQLV K66
S67-p
AISKRFksQTDQLVL
0 1
UBQLN2 (human) AISKRFksQTDQLVL S67-p
UBQLN2 (mouse) AISKRFkSQTDQLVL S67
UBQLN2 (rat) AISKRFKSQTDQLVL S67
K79-ub
LVLIFAGkILkDQDT
0 22
UBQLN2 (human) LVLIFAGkILkDQDT K79-ub
UBQLN2 (mouse) LVLIFAGkILKDQDT K79-ub
UBQLN2 (rat) LVLIFAGKILKDQDT K79
K82-ub
IFAGkILkDQDTLIQ
0 3
UBQLN2 (human) IFAGkILkDQDTLIQ K82-ub
UBQLN2 (mouse) IFAGkILKDQDTLMQ K82
UBQLN2 (rat) IFAGKILKDQDTLIQ K82
T123-p
SNAAGTNtTSAStPR
0 1
UBQLN2 (human) SNAAGTNtTSAStPR T123-p
UBQLN2 (mouse) STTAGTSTTTTTTTT T124
UBQLN2 (rat) STTAGTSTTTTTTTT T124
T128-p
TNtTSAStPRSNSTP
0 33
UBQLN2 (human) TNtTSAStPRSNSTP T128-p
UBQLN2 (mouse) TSTTTTTTTTAAAPA T129
UBQLN2 (rat) TSTTTTTTTTAAAPP T129
S222-p
IQRNPEIsHLLNNPD
0 1
UBQLN2 (human) IQRNPEIsHLLNNPD S222-p
UBQLN2 (mouse) IQRNPEISHLLNNPD S233
UBQLN2 (rat) IQRNPEISHLLNNPD S234
S256-p
RNQDLALsNLESIPG
0 7
UBQLN2 (human) RNQDLALsNLESIPG S256-p
UBQLN2 (mouse) RNQDLALsNLESIPG S267-p
UBQLN2 (rat) RNQDLALSNLESIPG S268
Y265-p
LESIPGGyNALRRMY
Upstream
0 19
Treatment
  • nocodazole
UBQLN2 (human) LESIPGGyNALRRMY Y265-p
UBQLN2 (mouse) LESIPGGYNALRRMY Y276
UBQLN2 (rat) LESIPGGYNALRRMY Y277